Trial · NCT03684772
Topical Ionic Contra-Viral Therapy in Actinic Keratosis
NCT03684772, Phase 2, Unknown, Maruho Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Topical Ionic Contra-Viral Therapy in Actinic Keratosis. Trials, record NCT03684772. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03684772
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Topical Ionic Contra-Viral Therapy in Actinic Keratosis
- NCT number
- NCT03684772
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 32 participants, estimated
- Lead sponsor
- Maruho Co., Ltd.
- Conditions
- Actinic Keratosis
- Interventions
- ICVT Topical Gel, Furosemide Topical Gel, Digoxin Topical Gel, Vehicle Topical Gel
- First posted
- 2018-09-26
- Last updated
- 2019-05-01
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Complete clinical clearance (CCC) per field | Day 42 | |
| Primary | Change in AK-FAS (AK field assessment scale) | Day 42 | AK Grade 0-IV, the higher the number the more % area covered by AK |
| Primary | Investigator global score (IGS) of each field | Day 126 | This is a 7 point scale from -2 (significantly worse) to +4 (completely cured), higher values represent a better outcome |
| Primary | Evolution of one assigned target lesion in the field, assessed by dermoscopy | Day 126 | assessing erythema, scaling, pigmentation, and follicular plug |
| Primary | Field morphology | Day 126 | Change in lesion count per field |
| Primary | Standardized photography with Canfield VISIA or 2D photography and with Antera 3D camera | Day 126 | |
| Primary | Biopsy biomarker | Day 126 | Analysis will be prerformed for the following biomarker: IFN-a. IFN-g, Ki-67 |
| Primary | Biopsy biomarker | Day 126 | Analysis will be prerformed for the following biomarker: IFN-g |
| Primary | Biopsy biomarker | Day 126 | Analysis will be prerformed for the following biomarker: Ki-67 |
| Primary | Biopsy biomarker | Day 126 | Analysis will be prerformed for the following biomarker: p53 |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03684772
GET https://conductscience.org/api/trials/v1/NCT03684772/registered?page=2